OXOS Medical has filed a notice of an exempt offering of securities to raise $23,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, OXOS Medical is raising $23,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Evan Ruff played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About OXOS Medical
OXOS Medical puts the future of x-ray in your hands. OXOS Micro C, the first handheld X-ray system, is faster, safer, and smarter than conventional C arms and is available now. The company entered the $50 billion U.S. diagnostic radiology market with the U.S. Food and Drug Administration 510k clearance in 2021 of its Micro C Medical Imaging System, a complete, handheld dynamic digital radiography system. Micro C brings radiologic diagnosis to the point-of-care with a handheld X-ray that operates safely without a radiation suite. The cloud-based OXOS Platform offers growing capabilities for on-demand image management, telehealth collaboration, and delivery of AI diagnostics.
To learn more about OXOS Medical, visit http://oxos.com/
Contact:
Evan Ruff, Chief Executive Officer
855-733-9729
https://www.linkedin.com/in/evan-ruff/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.